Discussion: Managing Risk When Using Idelalisib.

Discussion: Managing Risk When Using Idelalisib. Clin Adv Hematol Oncol. 2016 May;14 Suppl 8(5):13 Authors: Coutre SE, Burger JA, Pagel JM PMID: 27168205 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/27168205?dopt=Abstract

Source: Clinical Advances in Hematology and Oncology - May 12, 2016 Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research

More News: Cancer & Oncology | Hematology